アルブミンの世界市場レポート 2024年

アルブミン市場規模は、今後数年間で力強い成長が見込まれます。2028年にはCAGR9.1％で93億3,000万米ドルに成長します。予測期間に予想される成長は、肝疾患の有病率の増加、再生医療における用途の拡大、高齢者人口の増加、診断技術の進化、外来診療へのヘルスケアインフラのシフト、最適なタンパク質レベルを維持することの重要性に対する意識の高まりに起因すると考えられます。予測期間中の主な動向としては、治療用途の拡大、ドラッグデリバリー・システムへの採用拡大、細胞培養培地需要の増加、個別化医療の成長、遺伝子組換え技術の進歩、低アルブミン血症治療に対する意識の高まり、革新的なアルブミンに基づく製品の研究開発への多額の投資などが挙げられます。

糖尿病の有病率の増加は、アルブミン市場の今後の成長を牽引するものと思われます。糖尿病は、高血糖状態が長く続くことを特徴とする代謝性疾患で、栄養不良、座りがちなライフスタイル、ホルモン状態、肥満などの要因により増加傾向にあります。アルブミンは、重要なバイオマーカーとして糖尿病管理において重要な役割を果たし、インスリン治療の指針、血糖コントロールのモニタリング、診断の補助、糖尿病性ケトアシドーシス（DKA）などの合併症の予測に役立っています。アルブミン値を正常に保つことは、糖尿病を効果的に管理する上で極めて重要です。米国国立医学図書館によると、2021年の世界の糖尿病有病率は10.5％と推定され、20～79歳の約5億3,660万人が罹患しています。予測によると、この数字は2045年には12.2％に達し、約7億8,320万人が影響を受ける可能性があります。そのため、糖尿病罹患率の上昇がアルブミン市場の成長を促進すると予想されます。

アルブミン市場の大手企業は技術革新に注力しており、高度な機能を備えた需要の増加に対応するため、動物由来およびヒト由来の組み換えアルブミンなどの製品を開発しています。この種のアルブミンは、酵母のような非哺乳類発現系を用いて生産され、動物由来成分やヒト由来成分を含まないです。例えば、2023年3月、英国を拠点とする遺伝子組換えヒトアルブミン（rHA）の製造業者であるアルブメディックス社は、日本を拠点とする臨床段階のバイオテクノロジー企業であるハートシード社と提携し、ハートシード社の治験用細胞療法であるHS-001のヒト初臨床試験において、重要な賦形剤としてリコンビンを導入しました。この提携は、様々な疾患に対する革新的な治療アプローチが期待されるHS-001を推進する上で、重要なマイルストーンとなります。組換え技術の使用は、細胞治療の最適な性能と安定性を保証し、治療成功の可能性を高めます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界の市場規模と成長

• 世界のアルブミン市場：促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界のアルブミン市場の実績：規模と成長、2018年～2023年
• 世界のアルブミン市場の予測：規模と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界のアルブミン市場：タイプ別、実績と予測、2018年～2023年、2023年～2028年、2033年
• ヒト血清アルブミン
• 牛血清アルブミン
• 組み換えアルブミン
• 世界のアルブミン市場：用途別、実績と予測、2018年～2023年、2023年～2028年、2033年
• 治療薬
• 医薬品の処方とワクチン
• メディアの構成要素
• その他の用途
• 世界のアルブミン市場：販売チャネル別、実績と予測、2018年～2023年、2023年～2028年、2033年
• 企業対消費者（B2C）
• 企業間取引（B2B）
• 世界のアルブミン市場：エンドユーザー別、実績と予測、2018年～2023年、2023年～2028年、2033年
• 病院と診療所
• 製薬およびバイオテクノロジー企業
• 研究機関

第7章 地域別・国別分析

• 世界のアルブミン市場：地域別、実績と予測、2018年～2023年、2023年～2028年、2033年
• 世界のアルブミン市場：国別、実績と予測、2018年～2023年、2023年～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• アルブミン市場：競合情勢
• アルブミン市場：企業プロファイル
  • Bristol-Myers Squibb Company
  • Thermo Fisher Scientific Inc.
  • Takeda Pharmaceutical Company Limited
  • Merck KGaA
  • Baxter International Inc.

第31章 その他の大手企業と革新的企業

• CSL Limited
• Grifols SA
• Mitsubishi Tanabe Pharma Corporation
• Octapharma AG
• Kedrion S.p.A.
• Biotest AG
• Jiangxi Boya Bio-Pharmaceutical Co. Ltd.
• BPL（Bio Products Laboratory）
• Kamada Ltd.
• Proliant Biologicals
• SeraCare Life Sciences Inc.
• HiMedia Laboratories
• Albumedix Ltd.
• Medxbio Pte Ltd.
• Ventria Bioscience Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと潜在的な分析

第36章 付録

Albumin is a type of protein present in blood plasma, serum, muscle, egg whites, milk, and other animal substances, as well as in various plant tissues and fluids. It is a simple protein that is heat-coagulable and water-soluble, playing a vital role in maintaining fluid balance and transporting hormones, vitamins, and enzymes throughout the body.

The primary types of albumin are human serum albumin, bovine serum albumin, and recombinant serum albumin. Human serum albumin, found in blood plasma, helps maintain osmotic pressure and transports various substances such as hormones and fatty acids. Its applications include therapeutics, drug formulation, vaccines, and media components, distributed through channels such as business-to-customer (B2C) and business-to-business (B2B). The end users of albumin include hospitals and clinics, pharmaceutical and biotechnology companies, and research institutes.

The albumin research report is one of a series of new reports from The Business Research Company that provides albumin market statistics, including the albumin industry's global market size, regional shares, competitors with an albumin market share, detailed albumin market segments, market trends and opportunities, and any further data you may need to thrive in the albumin industry. This albumin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The albumin market size has grown strongly in recent years. It will grow from $6.03 billion in 2023 to $6.57 billion in 2024 at a compound annual growth rate (CAGR) of 9.0%. The growth during the historic period can be credited to advancements in biotechnology, a higher demand for plasma-derived therapies, expanding pharmaceutical applications, a high prevalence of liver diseases, regulatory approvals for albumin-based products, and the globalization of healthcare, which has led to wider market access.

The albumin market size is expected to see strong growth in the next few years. It will grow to $9.33 billion in 2028 at a compound annual growth rate (CAGR) of 9.1%. The growth expected in the forecast period can be attributed to the increasing prevalence of liver diseases, expanding applications in regenerative medicine, a rising geriatric population, evolving diagnostic techniques, a shift in healthcare infrastructure towards outpatient care, and growing awareness about the importance of maintaining optimal protein levels. Major trends during the forecast period include expanding therapeutic applications, increasing adoption in drug delivery systems, higher demand in cell culture media, growth in personalized medicine, advancements in recombinant technology, heightened awareness of hypoalbuminemia treatment, and significant investment in research and development for innovative albumin-based products.

The increasing prevalence of diabetes is poised to drive growth in the albumin market moving forward. Diabetes, a metabolic disorder characterized by prolonged high blood sugar levels, is on the rise due to factors such as poor nutrition, sedentary lifestyles, hormonal conditions, and obesity. Albumin plays a critical role in diabetes management as a significant biomarker, guiding insulin therapy, monitoring glycemic control, aiding diagnosis, and predicting complications such as diabetic ketoacidosis (DKA). Maintaining normal albumin levels is crucial for effectively managing diabetes. According to the National Library of Medicine, global diabetes prevalence was estimated at 10.5% in 2021, affecting approximately 536.6 million individuals aged 20-79 years. Projections suggest this figure could reach 12.2% by 2045, impacting about 783.2 million people. Therefore, the rising incidence of diabetes is expected to drive growth in the albumin market.

Leading companies in the albumin market are focusing on innovation, developing products such as animal- and human-origin-free recombinant albumin to meet increasing demand with advanced features. This type of albumin is produced using non-mammalian expression systems such as yeast and does not contain any animal- or human-derived components. For example, in March 2023, Albumedix, a UK-based manufacturer of recombinant human albumin (rHA), collaborated with Heartseed Inc., a Japan-based clinical-stage biotech company, to introduce Recombin as a critical excipient for Heartseed's investigational cell therapy, HS-001, during its first-in-human clinical trial. This partnership represents a significant milestone in advancing HS-001, promising innovative treatment approaches for various diseases. The use of recombinant technology ensures optimal performance and stability of the cell therapy, enhancing its potential for therapeutic success.

In September 2022, Sartorius AG, a Germany-based supplier of pharmaceutical and laboratory equipment, acquired Albumedix, strengthening its position in the expanding sector of advanced therapies and vaccines. This acquisition aligns Albumedix's innovative recombinant albumin technology with Sartorius' portfolio of cell culture media and process solutions, bolstering the company's offerings in the dynamic market landscape of advanced therapies. Albumedix Ltd. is a UK-based provider of high-quality recombinant human albumin solutions.

Major companies operating in the albumin market are Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Takeda Pharmaceutical Company Limited, Merck KGaA, Baxter International Inc., CSL Limited, Grifols SA, Mitsubishi Tanabe Pharma Corporation, Octapharma AG, Kedrion S.p.A., Biotest AG, Jiangxi Boya Bio-Pharmaceutical Co. Ltd., BPL (Bio Products Laboratory), Kamada Ltd., Proliant Biologicals, SeraCare Life Sciences Inc., HiMedia Laboratories, Albumedix Ltd., Medxbio Pte Ltd., Ventria Bioscience Inc., China Biologic Products Holdings Inc.

North America was the largest region in the albumin market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the albumin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the albumin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The albumin market consists of sales of egg albumin, plant-based albumin, and recombinant human albumin. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Albumin Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on albumin market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for albumin ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The albumin market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Human Serum Albumin; Bovine Serum Albumin; Recombinant Albumin
• 2) By Application: Therapeutics; Drug Formulation And Vaccines; Component Of Media; Other Applications
• 3) By Sales Channel: Business-To-Consumer (B2C); Business-To-Business (B2B)
• 4) By End-User: Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Research Institutes
• Companies Mentioned: Bristol-Myers Squibb Company; Thermo Fisher Scientific Inc.; Takeda Pharmaceutical Company Limited; Merck KGaA; Baxter International Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Albumin Market Characteristics

3. Albumin Market Trends And Strategies

4. Albumin Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Albumin Market Size and Growth

• 5.1. Global Albumin Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Albumin Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Albumin Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Albumin Market Segmentation

• 6.1. Global Albumin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Human Serum Albumin
• Bovine Serum Albumin
• Recombinant Albumin
• 6.2. Global Albumin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Therapeutics
• Drug Formulation And Vaccines
• Component Of Media
• Other Applications
• 6.3. Global Albumin Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Business-To-Consumer (B2C)
• Business-To-Business (B2B)
• 6.4. Global Albumin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals And Clinics
• Pharmaceutical And Biotechnology Companies
• Research Institutes

7. Albumin Market Regional And Country Analysis

• 7.1. Global Albumin Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Albumin Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Albumin Market

• 8.1. Asia-Pacific Albumin Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Albumin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Albumin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Albumin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Albumin Market

• 9.1. China Albumin Market Overview
• 9.2. China Albumin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Albumin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Albumin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Albumin Market

• 10.1. India Albumin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Albumin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Albumin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Albumin Market

• 11.1. Japan Albumin Market Overview
• 11.2. Japan Albumin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Albumin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Albumin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Albumin Market

• 12.1. Australia Albumin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Albumin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Albumin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Albumin Market

• 13.1. Indonesia Albumin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Albumin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Albumin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Albumin Market

• 14.1. South Korea Albumin Market Overview
• 14.2. South Korea Albumin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Albumin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Albumin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Albumin Market

• 15.1. Western Europe Albumin Market Overview
• 15.2. Western Europe Albumin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Albumin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Albumin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Albumin Market

• 16.1. UK Albumin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Albumin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Albumin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Albumin Market

• 17.1. Germany Albumin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Albumin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Albumin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Albumin Market

• 18.1. France Albumin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Albumin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Albumin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Albumin Market

• 19.1. Italy Albumin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Albumin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Albumin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Albumin Market

• 20.1. Spain Albumin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Albumin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Albumin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Albumin Market

• 21.1. Eastern Europe Albumin Market Overview
• 21.2. Eastern Europe Albumin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Albumin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Albumin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Albumin Market

• 22.1. Russia Albumin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Albumin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Albumin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Albumin Market

• 23.1. North America Albumin Market Overview
• 23.2. North America Albumin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Albumin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Albumin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Albumin Market

• 24.1. USA Albumin Market Overview
• 24.2. USA Albumin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Albumin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Albumin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Albumin Market

• 25.1. Canada Albumin Market Overview
• 25.2. Canada Albumin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Albumin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Albumin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Albumin Market

• 26.1. South America Albumin Market Overview
• 26.2. South America Albumin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Albumin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Albumin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Albumin Market

• 27.1. Brazil Albumin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Albumin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Albumin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Albumin Market

• 28.1. Middle East Albumin Market Overview
• 28.2. Middle East Albumin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Albumin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Albumin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Albumin Market

• 29.1. Africa Albumin Market Overview
• 29.2. Africa Albumin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Albumin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Albumin Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Albumin Market Competitive Landscape And Company Profiles

• 30.1. Albumin Market Competitive Landscape
• 30.2. Albumin Market Company Profiles
  • 30.2.1. Bristol-Myers Squibb Company
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Thermo Fisher Scientific Inc.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Takeda Pharmaceutical Company Limited
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Merck KGaA
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Baxter International Inc.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Albumin Market Other Major And Innovative Companies

• 31.1. CSL Limited
• 31.2. Grifols SA
• 31.3. Mitsubishi Tanabe Pharma Corporation
• 31.4. Octapharma AG
• 31.5. Kedrion S.p.A.
• 31.6. Biotest AG
• 31.7. Jiangxi Boya Bio-Pharmaceutical Co. Ltd.
• 31.8. BPL (Bio Products Laboratory)
• 31.9. Kamada Ltd.
• 31.10. Proliant Biologicals
• 31.11. SeraCare Life Sciences Inc.
• 31.12. HiMedia Laboratories
• 31.13. Albumedix Ltd.
• 31.14. Medxbio Pte Ltd.
• 31.15. Ventria Bioscience Inc.

32. Global Albumin Market Competitive Benchmarking

33. Global Albumin Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Albumin Market

35. Albumin Market Future Outlook and Potential Analysis

• 35.1 Albumin Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Albumin Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Albumin Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer